Page last updated: 2024-08-05 11:33:48

cyclic dicarboxylic anhydride

An acid anhydride derived by loss of water between two carboxylic groups in the same molecule so as to close a ring.

ChEBI ID: 36609

Members (10)

MemberDefinitionRole
1,8-naphthalenedicarboxylic acid anhydrideNaphthalic anhydride
cantharidinA monoterpenoid with an epoxy-bridged cyclic dicarboxylic anhydride structure secreted by many species of blister beetle, and most notably by the Spanish fly, Lytta vesicatoria. Natural toxin inhibitor of protein phosphatases 1 and 2A.cantharidin
cornexistinA cyclic dicarboxylic anhydride that is 5,6,7,8,9,10-hexahydro-1H-cyclonona[c]furan-1,3(4H)-dione substituted by an ethylidene group at position 9, hydroxy groups at position 5 and 8, a propyl group at position 4 and an oxo group at position 6.14-dihydroxycornestin
glutaric anhydrideA cyclic dicarboxylic anhydride that is oxane which carries oxo groups at positions 2 and 6. It is used as an intermediate in the production of pharmaceuticals, corrosion inhibitors, and polymers (E.g. epoxy polyesters).glutaric anhydride
maleic anhydrideA cyclic dicarboxylic anhydride that is the cyclic anhydride of maleic acid.maleic anhydride
phthalic anhydrideThe cyclic dicarboxylic anhydride that is the anhydride of phthalic acid.phthalic anhydride
succinic anhydridesuccinic anhydride
tetrabromophthalic anhydrideTetrabromophthalic anhydride
tetrachlorophthalic anhydrideA cyclic dicarboxylic anhydride that is phthalic anhydride chlorinated at the 4-, 5-, 6- and 7-positions.tetrachlorophthalic anhydride
trimellitic anhydrideA 2-benzofuran compound having oxo groups at the 1- and 3-positions and a carboxy substituent at the 5-position; the cyclic anhydride formed from the carboxy groups at the 1- and 2-positions of trimellitic acid.trimellitic anhydride

Research

Studies (2,177)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-1990525 (24.12)18.7374
1990's335 (15.39)18.2507
2000's449 (20.62)29.6817
2010's631 (28.98)24.3611
2020's237 (10.89)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials44 (1.87%)5.53%
Reviews96 (4.09%)6.00%
Case Studies111 (4.73%)4.05%
Observational1 (0.04%)0.25%
Other2,095 (89.26%)84.16%